Catalyst Pharmaceuticals Announces Third Quarter 2014 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/24/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
Catyalyst Pharmaceutical (CPRX) Posts Q3 Loss of 6c/Share
November 14, 2014 8:05 AM ESTCatyalyst Pharmaceutical (NASDAQ: CPRX) reported Q3 EPS of ($0.06), $0.01 worse than the analyst estimate of ($0.05).
For earnings history and earnings-related data on Catyalyst Pharmaceutical (CPRX) click here.
... More


